NEW
YORK, July 2, 2024 /PRNewswire/ -- Kuehn Law, PLLC, a shareholder litigation law
firm, is investigating whether certain officers and directors
of Intellia Therapeutics, Inc. (NASDAQ: NTLA) breached their
fiduciary duties to shareholders. The investigation concerns
potential self-dealing. Shareholders may be entitled to
damages and corporate governance reforms.
If you own NTLA please contact Justin Kuehn,
Esq. by email at justin@kuehn.law or call (833)
672-0814. The consultation and case are free with no
obligation to you. Kuehn Law
pays all case costs and does not charge its investor clients.
Shareholders should contact the firm immediately as there may be
limited time to enforce your rights.
Why Your Participation Matters:
As a shareholder your voice matters, and by getting involved,
you contribute to the integrity and fairness of the financial
markets. Your investment. Your voice. Your
future.™
For additional information, please visit Shareholder Derivative
Litigation - Kuehn Law.
Attorney advertising. Prior results do not guarantee similar
outcomes.
Contacts:
Kuehn Law, PLLC
Justin Kuehn, Esq.
53 Hill Street, Suite 605
Southampton, NY 11968
justin@kuehn.law
(833) 672-0814
View original content to download
multimedia:https://www.prnewswire.com/news-releases/kuehn-law-encourages-investors-of-intellia-therapeutics-inc-to-contact-law-firm-302188087.html
SOURCE Kuehn Law, PLLC